AtriCure ATRC
$55.39 +$1.28 (+2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $55.39 0.00%
Open$54.03
Prev close$54.11
Day range$54.03 – $56.19
Volume813.1K
Market cap$2.82B
P/E (TTM)178.7
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$154.45M+15.0% YoY
Operating profit$4.35M+1,992.8% YoY
Net profit$4.06M+1,622.1% YoY
Diluted EPS$0.08+900.0% YoY
Free cash flow$19.43M-19.4% YoY
Operating cash flow$30.32M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin76.7%
Operating margin2.9%
Net margin2.5%
Return on equity2.9%
Return on assets2.2%
Return on invested capital2.6%
Current ratio4.33
Liabilities / assets25.7%
Cash & investments$187.03M
Total debt$93.11M
Net cash (debt)$93.93M
Free cash flow / sales8.0%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $154.45M | $153.60M | $141.25M | $534.53M | $140.50M |
| Total Operating Revenue | $154.45M | $153.60M | $141.25M | $534.53M | $140.50M |
| Cost of Revenue | $35.10M | $34.98M | $31.94M | $133.75M | $35.16M |
| Gross Profit | $119.35M | $118.63M | $109.31M | $400.78M | $105.34M |
| Operating Expense | $115.00M | $108.96M | $108.79M | $410.23M | $102.85M |
| Selling and Admin Expenses | $82.88M | $82.56M | $84.55M | $311.02M | $78.34M |
| Research & Development | $32.12M | $26.40M | $24.24M | $99.21M | $24.51M |
| Operating Profit | $4.35M | $9.67M | $526,000.00 | -$9.45M | $2.49M |
| Net Non-Operating Interest Income (Expense) | -$213,000.00 | -$139,000.00 | -$95,000.00 | -$1.40M | -$173,000.00 |
| Non-Operating Interest Income | $1.40M | $1.18M | $1.25M | $4.48M | $1.33M |
| Non-Operating Interest Expense | $1.61M | $1.32M | $1.34M | $5.88M | $1.50M |
| Other Income (Expense) | -$123,000.00 | -$100,000.00 | -$37,000.00 | $683,000.00 | $42,000.00 |
| Other Non-Operating Income (Expenses) | -$123,000.00 | -$100,000.00 | -$37,000.00 | $683,000.00 | $42,000.00 |
| Pretax Profit | $4.02M | $9.43M | $394,000.00 | -$10.16M | $2.36M |
| Tax | -$47,000.00 | $471,000.00 | $286,000.00 | $1.29M | $604,000.00 |
| Net Profit | $4.06M | $8.96M | $108,000.00 | -$11.45M | $1.76M |
| Profit from Continuing Operations | $4.06M | $8.96M | $108,000.00 | -$11.45M | $1.76M |
| Net Income to Parent Company | $4.06M | $8.96M | $108,000.00 | -$11.45M | $1.76M |
| Net Income to Common Stockholders | $4.06M | $8.96M | $108,000.00 | -$11.45M | $1.76M |
| Basic EPS | $0.08 | $0.18 | $0.00 | -$0.24 | $0.04 |
| Diluted EPS | $0.08 | $0.18 | $0.00 | -$0.24 | $0.04 |
| Special Income (Charges) | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $717.54M | $676.64M | $643.99M | $654.18M | $654.18M |
| Total Current Assets | $363.39M | $345.53M | $313.69M | $322.52M | $322.52M |
| Cash and Cash Equivalents & Short-Term Investments | $187.03M | $167.79M | $146.17M | $167.43M | $167.43M |
| -Cash and Cash Equivalents | $187.03M | $167.79M | $146.17M | $167.43M | $167.43M |
| Receivables | $76.13M | $79.98M | $71.31M | $66.65M | $66.65M |
| -Accounts Receivable | $76.13M | $79.98M | $71.31M | $66.65M | $66.65M |
| Inventory | $87.31M | $83.93M | $81.14M | $78.49M | $78.49M |
| Other Current Assets | $12.92M | $13.84M | $15.07M | $9.94M | $9.94M |
| Total Non-Current Assets | $354.15M | $331.11M | $330.30M | $331.66M | $331.66M |
| Net PPE | $72.38M | $48.49M | $46.19M | $45.99M | $45.99M |
| -Gross PPE | $72.38M | $48.49M | $46.19M | $115.76M | $115.76M |
| Goodwill and Other Intangible Assets | $275.66M | $278.04M | $280.42M | $282.81M | $282.81M |
| -Goodwill | $234.78M | $234.78M | $234.78M | $234.78M | $234.78M |
| -Other Intangible Assets | $40.88M | $43.26M | $45.64M | $48.03M | $48.03M |
| Other Non-Current Assets | $6.11M | $4.58M | $3.69M | $2.86M | $2.86M |
| Total Liabilities | $184.31M | $160.21M | $152.30M | $162.24M | $162.24M |
| Total Current Liabilities | $83.97M | $81.92M | $73.19M | $81.52M | $81.52M |
| Payables | $30.39M | $35.85M | $30.56M | $25.31M | $25.31M |
| -Accounts Payable | $30.39M | $35.85M | $30.56M | $25.31M | $25.31M |
| Current Accrued Expenses | $3.50M | $3.30M | $3.28M | $2.85M | $2.85M |
| Current Provisions | $4.01M | $4.01M | $3.97M | $3.48M | $3.48M |
| Other Current Liabilities | $3.73M | $3.17M | $3.13M | $3.12M | $3.12M |
| Total Non-Current Liabilities | $100.34M | $78.29M | $79.10M | $80.72M | $80.72M |
| Long Term Debt and Capital Lease Obligation | $93.11M | $71.05M | $71.78M | $73.38M | $73.38M |
| -Long Term Debt | $61.00M | $61.00M | $61.00M | $61.87M | $61.87M |
| -Long Term Capital Lease Obligation | $32.11M | $10.05M | $10.78M | $11.52M | $11.52M |
| Other Non-Current Liabilities | $7.24M | $7.25M | $7.32M | $7.34M | $7.34M |
| Total Equity | $533.22M | $516.43M | $491.69M | $491.94M | $491.94M |
| Stockholders' Equity | $533.22M | $516.43M | $491.69M | $491.94M | $491.94M |
| Capital Stock | $51,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| -Common Stock | $51,000.00 | $51,000.00 | $51,000.00 | $50,000.00 | $50,000.00 |
| Additional Paid-In Capital | $933.23M | $920.42M | $904.51M | $904.52M | $904.52M |
| Retained Earnings | -$400.08M | -$404.14M | -$413.10M | -$413.20M | -$413.20M |
| Gains/Losses Not Affecting Retained Earnings | $15,000.00 | $101,000.00 | $227,000.00 | $566,000.00 | $566,000.00 |
| -Accumulated Depreciation | – | – | – | -$69.77M | -$69.77M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $30.32M | $22.19M | -$4.00M | $57.33M | $20.03M |
| Net cash flow from continuing operations | $30.32M | $22.19M | -$4.00M | $57.33M | $20.03M |
| Net Income from Continuing Operations | $4.06M | $8.96M | $108,000.00 | -$11.45M | $1.76M |
| Depreciation & Depletion & Amortization | $5.48M | $5.31M | $5.27M | $20.53M | $5.11M |
| Other Non-Cash Items | $5.16M | $574,000.00 | $813,000.00 | $7.85M | $1.77M |
| Change in Working Capital | $3.14M | -$4.96M | -$21.46M | -$4.29M | $137,000.00 |
| -Change in Receivables | $3.78M | -$8.76M | -$5.02M | -$5.61M | -$3.76M |
| -Change in Inventory | -$3.44M | -$2.87M | -$2.77M | -$2.26M | $455,000.00 |
| -Change in Payables and Accrued Expense | $3.88M | $6.89M | -$7.94M | $6.04M | $2.43M |
| -Change in Other Current Assets | $903,000.00 | $1.20M | -$5.16M | -$328,000.00 | $1.36M |
| -Change In Other Working Capital | -$1.98M | -$1.42M | -$575,000.00 | -$2.13M | -$352,000.00 |
| Net cash flow from investing | -$10.89M | -$3.77M | -$3.85M | -$14.55M | -$2.60M |
| Net Cash Flow from Continuing Investing Activities | -$10.89M | -$3.77M | -$3.85M | -$14.55M | -$2.60M |
| Net PPE Purchase and Sale | -$6.39M | -$3.77M | -$3.85M | -$9.05M | -$1.60M |
| Net Intangibles Purchase and Sale | -$4.50M | – | – | -$6.00M | -$1.00M |
| Financing Cash Flow | -$26,000.00 | $3.26M | -$13.26M | $1.18M | $2.10M |
| Net Cash Flow from Continuing Financing Activities | -$26,000.00 | $3.26M | -$13.26M | $1.18M | $2.10M |
| Net Issuance Payments Of Debt | -$326,000.00 | -$334,000.00 | -$1.19M | -$1.20M | -$321,000.00 |
| Net Common Stock Issuance | -$543,000.00 | -$314,000.00 | -$11.44M | -$11.16M | -$228,000.00 |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $877,000.00 | $3.91M | $158,000.00 | $7.29M | $2.65M |
| Ending Cash Balance | $187.03M | $167.79M | $146.17M | $167.43M | $167.43M |
| Net Change in Cash | $19.41M | $21.69M | -$21.10M | $43.96M | $19.52M |
| Beginning Cash Balance | $167.79M | $146.17M | $167.43M | $122.72M | $147.87M |
| Effect of Exchange Rate Changes | -$163,000.00 | -$67,000.00 | -$160,000.00 | $747,000.00 | $40,000.00 |
| Free Cash Flow | $19.43M | $18.43M | -$7.85M | $42.28M | $17.43M |
| Net Investment Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Other Investing Changes | – | – | – | $500,000.00 | $0.00 |
| Net Other Financing Charges | – | – | – | $6.25M | $0.00 |
No comments yet — be the first to weigh in on ATRC.
Sign in to join the discussion.